Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human NPRA/NPR1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB4860SP
This item is not returnable.
View return policy
Description
NPRA/NPR1 Monoclonal specifically detects NPRA/NPR1 in Human samples. It is validated for Western Blot.Specifications
NPRA/NPR1 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
P16066 | |
NPR1 | |
Mouse myeloma cell line NS0-derived recombinant human NPRA/NPR1 Gly33-Glu473 Accession # P16066 | |
25 μg | |
Primary | |
Detects human NPRA/NPR1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse NPR1 or recombinant human NPR2 is observed. | |
Human | |
Purified |
Western Blot | |
377029 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
ANPa, ANP-A, ANPRA, ANPR-A, ANPRAEC 4.6.1.2, atrial natriuretic peptide receptor 1, Atrial natriuretic peptide receptor type A, atrionatriuretic peptide receptor A, GC-A, Guanylate cyclase A, GUC2A, GUCY2A, natriuretic peptide A type receptor, natriuretic peptide receptor A, natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptidereceptor A), NPR1, NPRA, NPR-A, Pndr | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
4881 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction